Revenue grew 7% to S$126.3m and net profit rose 18.2% to S$144.1m, driven by strong healthcare demand and higher investment income. Gross margin improved, but administrative expenses increased due to currency losses. Weaker consumer spending is expected ahead.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.